We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Below-Knee Stent Trial Approved

By HospiMedica staff writers
Posted on 07 Jul 2006
A clinical trial will investigate the use of minimally invasive stent placement to treat severe peripheral arterial disease (PAD) below the knee

The study will be the first in the United States to evaluate the Xpert expandable nitinol stent in the blood vessels below the knee. More...
The stent is manufactured by Abbott Vascular (Abbott Park, Il, USA) and is currently cleared in the United States for treating blockages in the biliary ducts that carry digestive enzymes from the liver. The self-expanding stent is a tiny cylinder made of metal mesh that is guided into place by a catheter through the blood vessels to the site of the blockage under x-ray guidance. The stent is deployed through the catheter and expanded to prop open the diseased artery.

"The Xpert stent is particularly appropriate for this trial because it is the only self-expanding stent that comes in a variety of sizes small enough to treat the blood vessels below the knee,” said principal investigator Dr. James Joye of El Camino Hospital (Mountain View, CA, USA), which will be among the sites participating in the study. The study is also important because it is one of only a very few independent, physician-sponsored efforts.”

The trial is sponsored by VIVA Physicians Inc. (VPI, Rosemont, IL, USA), a multi-disciplinary group of independent doctors who are nationally known experts in the diagnosis and management of peripheral vascular diseases and who have joined together to advance education in vascular medicine and support research and innovative treatment options. VPI set the protocol, applied for the investigational device exemption (IDE), and is responsible for data collection, evaluation, and reporting of the Xpert stent study, called XCELL.



Related Links:
Abbott Vascular

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Infrared Digital Thermometer
R1B1
Pulmonary Ventilator
OXYMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.